1. Home
  2. SNGX vs IHT Comparison

SNGX vs IHT Comparison

Compare SNGX & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.15

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Logo InnSuites Hospitality Trust Shares of Beneficial Interest

IHT

InnSuites Hospitality Trust Shares of Beneficial Interest

HOLD

Current Price

$1.01

Market Cap

9.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
IHT
Founded
1987
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.2M
9.4M
IPO Year
2006
1995

Fundamental Metrics

Financial Performance
Metric
SNGX
IHT
Price
$1.15
$1.01
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
170.8K
4.4K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
1.96%
EPS Growth
57.03
N/A
EPS
N/A
N/A
Revenue
$119,371.00
$7,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.33
52 Week Low
$1.00
$0.95
52 Week High
$6.23
$4.24

Technical Indicators

Market Signals
Indicator
SNGX
IHT
Relative Strength Index (RSI) 44.38 38.11
Support Level $1.01 $0.95
Resistance Level $1.47 $1.12
Average True Range (ATR) 0.09 0.04
MACD -0.01 0.00
Stochastic Oscillator 43.75 37.50

Price Performance

Historical Comparison
SNGX
IHT

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About IHT InnSuites Hospitality Trust Shares of Beneficial Interest

InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.

Share on Social Networks: